MedTrace Logo

Acitretin and Etanercept in Psoriasis

NCT00156247 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-02-16

Study results available
· View outcomes & findings →

Summary

To determine whether acitretin plus etanercept is more effective than etanercept alone in clearing psoriasis plaques in adults.

Conditions

Interventions

DRUG

acitretin

Patients who have been taking etanercept 50 mg/week for at least 3 months (12 weeks) will take acitretin 25 mg pill once daily for 6 months.

Sponsors & Collaborators

  • Connetics Corp.

    collaborator UNKNOWN

  • University of Medicine and Dentistry of New Jersey

    lead OTHER

Principal Investigators

  • Melissa A. Magliocco, MD · Rutgers, The State University of New Jersey

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2009-03-31
Completion
2009-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156247 on ClinicalTrials.gov